Vorapaxar for Prevention of Major Adverse Cardiovascular and Limb Events in Peripheral Artery Disease

Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association

(2021) Michael H. Criqui et al.   CIRCULATION

Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association

(2020) Salim S. Virani et al.   CIRCULATION

Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trial

(2020) Arman Qamar et al.   VASCULAR MEDICINE

Rivaroxaban in Peripheral Artery Disease after Revascularization

(2020) Marc P. Bonaca et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the Evidence

(2020) Jeffrey Ian Weitz et al.   THROMBOSIS AND HAEMOSTASIS

Polyvascular disease: A narrative review of current evidence and a consideration of the role of antithrombotic therapy

(2020) E. Hope Weissler et al.   ATHEROSCLEROSIS

Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia

(2019) Michael S. Conte et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

(2018) Sonia S Anand et al.   LANCET

2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease

(2017) Marie D. Gerhard-Herman et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease

(2017) William R. Hiatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease

(2017) Marc P. Bonaca et al.   CIRCULATION

Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery DiseaseCLINICAL PERSPECTIVE

(2016) Marc P. Bonaca et al.   CIRCULATION

Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery DiseaseClinical Perspective

(2016) W. Schuyler Jones et al.   CIRCULATION

Nationwide Trends of Hospital Admission and Outcomes Among Critical Limb Ischemia Patients

(2016) Shikhar Agarwal et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease

(2016) Marc P. Bonaca et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Pharmacological Treatment and Current Management of Peripheral Artery Disease

(2015) M. P. Bonaca et al.   CIRCULATION RESEARCH

Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population

(2014) Mark R. Nehler et al.   JOURNAL OF VASCULAR SURGERY

Vorapaxar in Patients With Peripheral Artery Disease

(2013) Marc P. Bonaca et al.   CIRCULATION

Acute Limb Ischemia

(2012) Mark A. Creager et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lower extremity amputations - a review of global variability in incidence

(2011) P. W. Moxey et al.   DIABETIC MEDICINE

Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial

(2010) Jill J.F. Belch et al.   JOURNAL OF VASCULAR SURGERY